Cas:303798-10-9 (2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine manufacturer & supplier

Chemical Name:(2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine

CAS.NO:303798-10-9

Synonyms:(2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine

Molecular Formula:C₉H₁₀N₄S

Molecular Weight:206.26700

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:460.4ºC at 760 mmHg

Density:1.525g/cm3

Index of Refraction:1.829

PSA:92.07000

Exact Mass:206.06300

LogP:2.23890

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine Use and application,(2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine technical grade,usp/ep/jp grade.

Related News: We manufacture APIs and drug manufacturers make medicines from APIs. (2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine manufacturer The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. (2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine supplier The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. (2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine vendor In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth. (2,3-dihydro-1h-8-thia-5,7-diaza-cyclopenta[a]inden-4-yl)-hydrazine factory Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.